Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

GE acquires Amersham PLC for £5.7bn

Executive Summary

In an all-stock deal, General Electric Co. will acquire Amersham PLC for £5.7bn ($9.4bn). Amersham stockholders get 0.4367 of a new GE share for each of their own; the transaction values Amersham shares at $13.32, about a 45% premium to the company's trading price the day before its announcement.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register